Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Mochida Pharmaceutical Co., Ltd. (4534)
Market Closed
10 Aug, 06:00
JPX
All
(3)
DE
(2)
JP
(1)
XDUS
Primary
JPX
XFRA
¥
3,240.
00
+30
+0.9346%
¥
123.9B
Market Cap
-
P/E Ratio
80%
Div Yield
38,700
Volume
-
Eps
¥
3,210
Previous Close
Watching
Watch
Add Transaction
Day Range
3,205
3,250
Year Range
2,929
3,965
Want to track
4534
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Mochida Pharmaceutical Co., Ltd. (4534) Statistics
Valuation metrics
Market Cap
123.9B
Enterprise value
95.89B
Trailing P/E (ttm)
12.38
Forward P/E
19.2
PEG ratio
0.24
Price/Sales (ttm)
0.93
Price/Book (mrq)
0.81
Enterprise Value/Revenue
0.79
Enterprise Value/EBITDA
6.78
Overview
Shares outstanding
35.45M
Float
23.2M
Shares short
-
% Held by insiders
0.36%
% Held by institutions
0.15%
Average volume (10 days)
84.71K
Average volume (90 days)
67.2K
Price summary
52-Week low
2,929
52-Week high
3,965
Beta
-
50-Day moving average
3,153.14
200-Day moving average
3,437.68
Dividends and splits
Forward annual dividend rate
80
Forward annual dividend yield
0.0223%
Trailing annual dividend rate
80
Trailing annual dividend yield
0.0249%
5-Year annual dividend yield
2.44%
Payout ratio
0.42
Dividend Date
1 Dec 2025
Ex-Dividend Date
29 Sep 2025
Last split factor
2:1
Last split Date
27 Mar 2019
Financials
Fiscal year
Fiscal year ends
31 Mar 2025
Most recent quarter (mrq)
30 Jun 2025
Profitability
Profit margin
0.08%
Operating margin
0.09%
Operational effectiveness
Return on assets
0.05%
Return on equity
0.07%
Income Statement
Revenue (ttm)
111.91B
Revenue per share (ttm)
3,446.65
Quarterly revenue growth (yoy)
0.1%
Gross profit (ttm)
54.2B
EBITDA
11.01B
Net income to common (ttm)
6.42B
Diluted EPS (ttm)
259.46
Quarterly earnings growth (yoy)
-0.11%
Balance Sheet
Total cash (mrq)
41.5B
Total cash per share (mrq)
802.28
Total debt (mrq)
10B
Total Debt/Equity (mrq)
0.08
Current ratio (mrq)
3.94%
Book value per share (mrq)
3,962.21
Cash Flow
Cash flow statement
9.79B
Levered free cash flow (LFCF)
5.68B